2nd edition. — Humana Press, 2022. — 535 p. — (Methods in Molecular Biology 2412). — ISBN 978-1-0716-1891-2.
This volume provides a practical guide providing step-by-step methods and protocols on vaccine development and production. Divided into three volumes, Volume 3: Resources for Vaccine Development guides readers through chapters on vaccine adjuvants, vaccine vectors, production, vaccine delivery systems, vaccine bioinformatics, vaccine regulation, and intellectual property. Written in the format of the highly successful Methods in Molecular Biology series, each chapter includes an introduction to the topic, lists necessary materials and reagents, includes tips on troubleshooting and known pitfalls, and step-by-step, readily reproducible protocols.This volume provides a practical guide providing step-by-step methods and protocols on vaccine development and production. Divided into three volumes, Volume 3: Resources for Vaccine Development guides readers through chapters on vaccine adjuvants, vaccine vectors, production, vaccine delivery systems, vaccine bioinformatics, vaccine regulation, and intellectual property. Written in the format of the highly successful Methods in Molecular Biology series, each chapter includes an introduction to the topic, lists necessary materials and reagents, includes tips on troubleshooting and known pitfalls, and step-by-step, readily reproducible protocols.
Trends in Vaccine DevelopmentArtificial Intelligence for Vaccine Design
Progress in the Development of Structure-Based Vaccines
Polymer–Peptide Conjugate Vaccine for Oral Immunization
An Update on “Reverse Vaccinology”: The Pathway from Genomes and Epitope Predictions to Tailored, Recombinant Vaccines
Vaccine Vectors and Production SystemPhage T7 as a Potential Platform for Vaccine Development
Plant-Based Systems for Vaccine Production
Production of a Hepatitis E Vaccine Candidate Using the Pichia pastoris Expression System
Vaccine AdjuvantsDevelopments in Vaccine Adjuvants
Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines
Cationic Nanostructures as Adjuvants for Vaccines
Emulsion Adjuvants for Use in Veterinary Vaccines
Generation of a Liposomal Vaccine Adjuvant Based on Sulfated S-Lactosylarchaeol (SLA) Glycolipids
Glucan Particles: Choosing the Appropriate Size to Use as a Vaccine Adjuvant
Vaccine Delivery SystemsUse of Optical In Vivo Imaging to Monitor and Optimize Delivery of Novel Plasmid-Launched Live-Attenuated Vaccines
Liposomes for the Delivery of Lipopeptide Vaccines
Current Prospects in Peptide-Based Subunit Nanovaccines
Design and Synthesis of Protein-Based Nanocapsule Vaccines
Design and Preparation of Solid Lipid Nanoparticle (SLN)-Mediated DNA Vaccines
Nano-Particulate Platforms for Vaccine Delivery to Enhance Antigen-Specific CD8+ T-Cell Response
PilVax: A Novel Platform for the Development of Mucosal Vaccines
Vaccine BioinformaticsBioinformatic Techniques for Vaccine Development: Epitope Prediction and Structural Vaccinology
Immunoinformatic Approaches for Vaccine Designing for Pathogens with Unclear Pathogenesis
In Silico Identification of the B-Cell and T-Cell Epitopes of the Antigenic Proteins of Staphylococcus aureus for Potential Vaccines
Computational Mining and Characterization of Hypothetical Proteins of Mycobacterium bovis Toward the Identification of Probable Vaccine Candidates
Recombinant Vaccine Design Against Clostridium spp. Toxins Using Immunoinformatics Tools
Searching Epitope-Based Vaccines Using Bioinformatics Studies
Vaccine Safety and RegulationThe Regulatory Evaluation of Vaccines for Human Use
Vaccine Intellectual PropertyIntellectual Property Rights and Vaccines
Vaccine Intellectual Property
Pathways to Vaccine CommercializationResources for Starting a Company